This likely reflects the distinct nature of the two subsets and a growth/proliferation signature with preferential up-regulation of c-MYC in the lymph node tumor cells of U-CLL rather than M-CLL [23,24]. Here, MYC is linked to B-cell chronic lymphocytic leukemia.